ArticleJournal of thoracic disease2022

Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt/β-catenin signaling pathway.

Shuxin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.